Jenburkt Pharmaceuticals share news and announcements
NSE: JENBURPHBSE: 524731Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 23 Oct 2026. Previous close ₹871.40.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹384 Cr1,871st largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 6 Aug 2026
- 11.7
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹3.95 crore of one-off items, the largest of them in the quarter to Mar 2026.
- 10.5
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 5 May 2026
- 2.0
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 2.38%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 6 Aug 2026
- 17.8%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹3.95 crore of one-off items, the largest of them in the quarter to Mar 2026.
- 19.9%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 6 Aug 2026
- 19.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 5 May 2026
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 2,34093.5% delivered
Jenburkt Pharmaceuticals share news and announcements
651 announcements, routine notices left out, newest first. Page 4 of 14.
Jan 2023
31 Jan · Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares
30 Jan · Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares
27 Jan · Board meeting
Meeting on 7 Feb 2023: quarterly results27 Jan · Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares
25 Jan · Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares
24 Jan · Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares
23 Jan · Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares
20 Jan · Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares
19 Jan · Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares
18 Jan · Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares
17 Jan · Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares
16 Jan · Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares
13 Jan · Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares
12 Jan · Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares
11 Jan · Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares
11 Jan · Extinguishment Of Equity Shares Pursuant To Buyback Of Shares By The Company
10 Jan · Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares
9 Jan · Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares
6 Jan · Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares
5 Jan · Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares
4 Jan · Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares
3 Jan · Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares
2 Jan · Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares
Dec 2022
30 Dec · Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares
30 Dec · Extinguishment Of Equity Shares Pursuant To Buyback Of Shares By The Company
29 Dec · Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares
28 Dec · Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares
28 Dec · Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares
27 Dec · Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares
26 Dec · Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares
26 Dec · Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares
23 Dec · Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares
22 Dec · Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares
21 Dec · Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares
20 Dec · Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares
19 Dec · Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares
16 Dec · Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares
15 Dec · Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares
15 Dec · Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares
14 Dec · Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares
13 Dec · Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares
5 Dec · Corporate Action-Updates on Buy back
5 Dec · Announcement Under Reg. 30 Of SEBI-LODR About News Paper Publication
5 Dec · Corporate Action-Updates on Buy back
5 Dec · Announcement Under Regulations 30 Of SEBI-LODR Regarding Extract Of Minutes Of Buy-Back
1 Dec · Management
1 Dec · Corporate Action-Buy back
1 Dec · Board meeting